Asparagine preserves intestinal barrier function from LPS-induced injury and regulates CRF/CRFR signaling pathway

Innate Immunity

Volumn 23, Issue 6, 2017, Pages 546-556

  Zhu, Huiling ^a   Pi, Dingan ^a   Leng, Weibo ^a   Wang, Xiuying ^a   Hu, Chien An Andy ^a,b   Hou, Yongqing ^a   Xiong, Jianglin ^a   Wang, Chunwei ^a   Qin, Qin ^a   Liu, Yulan ^a  

^a WUHAN POLYTECHNIC UNIVERSITY   (China)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Asparagine; CRF CRFR1 signaling pathway; intestinal barrier function; lipopolysaccharide; weaned pigs

Indexed keywords

ASPARAGINE; CLAUDIN 1; CORTICOTROPHIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; TIGHT JUNCTION PROTEIN; TRYPTASE; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESCHERICHIA COLI; HISTOLOGY; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; INTESTINE INJURY; INTESTINE VILLUS ATROPHY; LAMINA PROPRIA; LYMPHOCYTE; MAST CELL; NEUTROPHIL COUNT; NONHUMAN; PIG; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ATROPHY; DEGRANULATION; DIET; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ASPARAGINE; ATROPHY; CELL DEGRANULATION; CLAUDIN-1; CORTICOTROPIN-RELEASING HORMONE; DIET; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MAST CELLS; NEUTROPHILS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; SWINE;

EID: 85026914240     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425917721631     Document Type: Article

References (48)

1. Suzuki T, Hara H,. Quercetin enhances intestinal barrier function through the assembly of zonnula occludens-2, occluding, and claudin-1 and the expression of claudin-4 in caco-2 cells. J Nutr 2009; 139: 965-974.
2. Zareie M, Johnson-Henry K, Jury J, et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55: 1553-1560.
3. Söderholm JD, Perdue MH,. Stress and the gastrointestinal tract II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2001; 280: G7-G13.
4. Kuge T, Meerveld BGV, Sokabe M,. Stress-induced breakdown of intestinal barrier function in the rat: reversal by wood creosote. Life Sci 2006; 79: 913-918.
5. Wiley JW, Higgins GA, Athey BD,. Stress and glucocorticoid receptor transcriptional programming in time and space: implications for the brain-gut axis. Neurogastroenterol Motil 2016; 28: 12-25.
6. Teitelbaum AA, Gareau MG, Jury J, et al. Chronic peripheral administration of corticotrophin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am J Physiol Gastrointest Liver Physiol 2008; 295: G452-G459.
7. Overman EL, Rivier JE, Moeser AJ,. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-α. PLOS ONE 2012; 7: 1-9.
8. Smith F, Clark JE, Overman BL, et al. Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am J Physiol Gastrointest Liver Physiol 2010; 298: G352-G363.
9. Viana ML, Santos RGC, Generoso SV, et al. The role of L-arginine-nitric oxide pathway in bacterial translocation. Amino Acids 2013; 45: 1089-1096.
10. Ferreira TM, Leonel AJ, Melo MA, et al. Oral supplementation of butyrate reduces mucosal and intestinal permeability associated with 5-fluorouracil administration. Lipids 2012; 47: 669-678.
11. Baumgart DC, Dignass AU,. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002; 5: 685-694.
12. Rhoads JM, Argenzio RA, Chen W, Gomez GG,. Asparagin stimulates piglet intestinal Cl secretion by a mechanism requiring a submucosal glutamate receptor and nitric oxide. J Pharmacol Exp Ther 1995; 274: 404-412.
13. McCormack SA, Tague LL, Cragoe EJ, Johnson LR,. Regulation of ornithine decarboxylase activity in LoVo cells. Am J Physiol 1990; 258: G934-G941.
14. Liu YL, Huang JJ, Hou YQ, et al. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr 2008; 100: 552-560.
15. Wieczorek M, Dunn AJ,. Noradrenergic and HPA responses to LPS following indomethacin or subdiaphragmatic vagotomy-a microdialysis study. Brain Behav Immun 2006; 20: e71-e81.
16. Becker BA, Nienaber JA, Christenson RK, et al. Peripheral concentrations of cortisol as an indicator of stress in the pig. Am J Vet Res 1985; 46: 1034-1038.
17. Johnson RW, von Borell E,. Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin. J Anim Sci 1994; 72: 309-314.
18. Moughan PJ, Birtles MJ, Cranwell PD, et al. The piglet as a model animal for studying aspects of digestion and absorption in milk-fed human infants. World Rev Nutr Diet 1992; 67: 40-113.
19. Wang XY, Liu YL, Li S, et al. Asparagine attenuates intestinal injury, improves energy status and inhibits AMP-activated protein kinase signaling pathways in weaned piglets challenged with Escherichia coli lipopolysaccharide. Br J Nutr 2015; 114: 553-565.
20. NRC. Nutrient requirements of swine, 10th ed. Washington, DC: National Academic Press, 1998.
21. Liu YL, Chen F, Li Q, et al. Fish oil alleviates activation of the hypothalamic-pituitary-adrenal axis associated with inhibition of TLR4 and NOD signaling pathways in weaned piglets after a lipopolysaccharide challenge. J Nutr 2013; 143: 1799-1807.
22. Yang RK, Han XN, Uchiyama T, et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol Gastrointest Liver Physiol 2003; 285: G621-G629.
23. -CT method. Methods 2001; 25: 402-408.
24. Gatt M, Reddy BS, MacFie J,. Review article: bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007; 25: 741-757.
25. Ziegler TR, Evans ME, Fernández-Estívariz C, Jones DP,. Trophic and cytoprotetive nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr 2003; 23: 229-261.
26. Corpeleijn WE, Riedijk MA, Zhou Y, et al. Almost all enteral asparate is taken up in first-pass metabolism in enterally fed preterm infants. Clin Nutr 2010; 29: 341-346.
27. Gao J, Zhang HJ, Yu SH, et al. Effects of yeast culture in broiler diets on performance and immunomodulatory functions. Poult Sci 2008; 8: 233-241.
28. Harhaj NS, Antonetti DA,. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004; 36: 1206-1237.
29. Ruan Z, Mi SM, Zhou LL, et al. Chlorogenic acid enhances intestinal barrier by decreasing MLCK expression and promoting dynamic distribution of tight junction proteins in colitic rats. J Funct Foods 2016; 26: 698-708.
30. Liu G, Guan GP, Fang J, et al. Macleaya cordata extract decreased diarrhea score and enhanced intestinal barrier function in growing piglets. Biomed Res Int 2016; 2016: 1069585-1069585.
31. Xiong X, Yang HS, Wang XC, et al. Effect of low dosage of chito-oligosacchride supplementation on intestinal morphology, immune response, antioxidant capacity, and barrier function in weaned piglets. J Anim Sci 2015; 93: 1089-1097.
32. Deventer SJH, Cate JW, Tytgat GNJ,. Intestinal endotoxemia. Clinical significance. Gastroenterology 1988; 94: 825-831.
33. Kandil HM, Argenzio RA, Chen W, et al. L-glutamine and L-asparagine stimulate ODC activity and proliferation in a procine jejunal enterocyte line. Gastrointest Liver Physiol 1995; 32: G591-G599.
34. Kudsk KA,. Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 2002; 183: 390-398.
35. Inagaki-Ohara K, Dewi FN, Hisaeda H, et al. Intestinal intraepithelial lymphocytes sustain the epithelial barrier function against Eimeria vermiformis infection. Infec Immun 2006; 74: 5292-5301.
36. Wang H, Zhang C, Wu GY, et al. Glutamine enhances tight junction protein expression and modulates corticotrophin releasing factor signaling in the jejunum of weanling piglets. J Nutr 2015; 145: 25-31.
37. Tache Y, Martinez V, Wang L, Million M,. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 2004; 141: 1321-1330.
38. Moeser AJ, Klok CV, Ryan KA, et al. Stress signaling pathways activated by weaning mediate intestinal dysfunction in the pig. Am J Physiol Gastrointest Liver Physiol 2007; 292: G173-G181.
39. Moussaoui N, Braniste V, Ait-Belgnaoui A, et al. Changes in intestinal glucocorticoid sensitivity in early life shape the risk of epithelial barrier defect in maternal-deprived rats. PLOS ONE 2014; 2: e88382-e88382.
40. Meddings JB, Swain MG,. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 2000; 119: 1019-1028.
41. Erwan E, Chowdhury VS, Nagasawa M, et al. Central injection of L- and D-aspartate attenuates isolation-induced stress behavior in chicks possibly through different mechanisms. Eur J Pharmacol 2014; 736: 138-142.
42. Santos J, Yang PC, Söderholm JD, et al. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630-636.
43. Vicario M, Guilarte M, Alonso C, et al. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Brain Behav Immun 2010; 24: 1166-1175.
44. Zhong CJ, Wang K, Zhang L, et al. Mast cell activation is involved in stress-induced epithelial barrier dysfunction in the esophagus. J Dig Dis 2015; 16: 186-196.
45. Guilarte M, Santos J, de Torres I, Alonso C, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-209.
46. Chadwick VS, Chen WX, Shu DR, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-1783.
47. He S, Gaça MD, Walls AF,. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 1998; 286: 289-297.
48. Jacob C, Yang PC, Darmoul D, et al. Mast cell tryptase controls paracellular permeability of the intestine: Role of protease-activated receptor 2 and β-arrestins. J Biol Chem 2005; 280: 31936-31948.